{"id":"NCT01478620","sponsor":"Bionorica SE","briefTitle":"Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)","officialTitle":"An Open-label, Non-randomized, Multicenter, Interventional Study to Investigate the Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2012-05","completion":"2012-08","firstPosted":"2011-11-23","resultsPosted":"2014-10-13","lastUpdate":"2019-02-27"},"enrollment":125,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Tract Infection"],"interventions":[{"type":"DRUG","name":"Canephron® N","otherNames":[]}],"arms":[{"label":"Canephron® N","type":"EXPERIMENTAL"}],"summary":"The objective of the study is to assess safety and impact of a non-antibiotic therapy approach with Canephron® N in the management strategy of uncomplicated lower urinary tract infections (UTIs).","primaryOutcome":{"measure":"Incidence of Adverse Drug Reactions During 7-day Treatment of uUTI Symptoms With Canephron® N","timeFrame":"During active treatment period (day 1 until day 7)","effectByArm":[{"arm":"Canephron® N","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":1,"countries":["Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":125},"commonTop":["Headache","Abdominal distension","Nausea","Pharyngitis","Respiratory tract infection"]}}